Bone Mineral Density Response With Denosumab in Combination With Standard or High-Dose Teriparatide: The DATA-HD RCT

CONTEXT: In the Denosumab and High-Dose Teriparatide Administration (DATA-HD) study, we reported that 15 months of combined high-dose (HD) teriparatide and denosumab increased mean areal bone mineral density (aBMD) at the hip and spine more than combined denosumab and standard-dose (SD) teriparatide...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Clin Endocrinol Metab
Hlavní autoři: Ramchand, Sabashini K, David, Natalie L, Leder, Benjamin Z, Tsai, Joy N
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2019
Témata:
Clinical Research Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7112977/
https://ncbi.nlm.nih.gov/pubmed/31674641
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/clinem/dgz163
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky